← Evidence map

ReviewDrugs2025

Minimal Residual Disease Negativity as the Primary Goal of Multiple Myeloma Therapy.

Jennifer H Cooperrider et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 40908381